Postoperative Stimulated Thyroglobulin ≤ 1 ng/ml as a Criterion to Spare Low-Risk Patients with Papillary Thyroid Cancer from Radioiodine Ablation

Managing newly diagnosed thyroid cancer

“…Other prognostic markers Some markers that are actively being studied for consideration in decision-making about treatment include serum thyroglobulin (a thyroid protein used as a surrogate marker for thyroid cancer after thyroidectomy, which may be stimulated [by thyroid hormone withdrawal or administration of recombinant human thyrotropin] or unstimulated [while on thyroid hormone treatment]) 20,21 and molecular tumour biomarkers such as mutations in the BRAF gene. 22 However, a detailed look at such research is beyond the scope of this review.…”